Search

Bacteria sometimes acquire "incorrect" CRISPR spacers in response to phage infection. Until now, no one knew whether these incorrect ("slipped") spacers had a purpose. Simon A. Jackson, Peter Fineran and co. have just shown that slipped spa

Could phages help explain the mysteriously healing qualities of India's Ganges river? If you're looking to learn about some interesting phage-related history (and mystery), you may like this excerpt of the new book "Ganges: The Many Pasts O

We are still seeking Citrobacter phages to treat a sea turtle's antibiotic-resistant shell infection. If you can help, please email staff@phage.directory! Progress so far: Good news! At least one phage active against the turtle's Citrobact

Gunaraj Dhungana Kathmandu, Nepal My name is Gunaraj Dhungana, I'm a Ph.D scholar from the central Department of Biotechnology, Tribhuvan University, Nepal. We have been working on the characterization and preparation of a phage bank to est

Our opinion piece, A Bright Outlook for Bacteriophage Applications, is featured in the Microbiome Times January 2019 edition (page 34).

Bioharmony Therapeutics and Boehringer Ingelheim just announced a collaboration to develop Acinetobacter baumannii lysin therapeutics.

CBC has provided a Canadian perspective on phage therapy (and there's a Quirks and Quarks radio show linked in the article!)

Phages for Global Health reached their 2018 fundraising goal, meaning they can deliver TWO phage workshops in 2019! Congratulations! And thanks to everyone who supports this one-of-a-kind phage nonprofit! Donate or sign up for their newslet

Jee-Hwan Oh and colleagues published a paper on how certain dietary sugars promote Lactobacillus phage production in the mouse gut.

PharmExec.com has named phage therapy as one of the top 10 drug discovery trends to watch in 2019!

Want to win one of 50 free copies of The Perfect Predator, the true story of how a global village saved the life of Tom Patterson with IV phage therapy? Sign up for the book giveaway on Goodreads.com by Jan 23. Note: you need to view it fro

Mahmuda Akter I have been working at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) and earned my M.S. degree from the University of Dhaka in Bangladesh. I was awarded joint funding from icddr,b and SIDA to i

Silviane Miruka I am a student seeking a PhD opportunity in a phage lab. I recently did a project for my master's thesis titled "Molecular Detection of Pathogenic Staphylococcus aureus Using Phage Based Genetic Markers." Please email me at

IPATH has just received FDA approval to start its first clinical trial! This will be the first US trial involving intravenous (IV) phage treatment, and will be a collaboration with Ampliphi Biosciences.

Adaptive Phage Therapeutics has partnered with Yale University to manufacture and supply phages for use in Yale's upcoming clinical trials.

Johnson & Johnson has invested $20 million (with another ~$800 million to follow if things go well) into Locus Biosciences, a biotech company equipping phages with CRISPR-Cas3 to obliterate bacterial DNA upon phage infection.

A phase II clinical trial for a phage lysin has been deemed successful! An anti-Staphylococcus aureus phage lysin, called exebacase, was just found to be both safe and effective at treating MRSA in patients. Exebacase is being developed by

The phage therapy biotech company Ampliphi Biosciences is merging with C3J Therapeutics, a synthetic phage/antimicrobial engineering company.

Due to the partial U.S. government shutdown, ASM is extending the deadline for ASM Microbe abstract submissions to January 25, 2019.

Thanks to support from Roche Molecular Diagnostics and Intralytix, ASM Division M will provide 4 travel awards to students presenting phage work at ASM Microbe 2019! To apply, use "phage" as a keyword in your submitted abstract. Before you